QIAGEN partners with U.K. to expand biomarker research in Manchester

QIAGEN announces broadening of GeneReader NGS System applications into hereditary disease analysis

QIAGEN launches new QIAseq 16S Panels and UCP Multiplex PCR kit enabling unbiased microbiome profiling

QIAGEN welcomes new guidelines from American Academy of Pediatrics for detecting tuberculosis infection in children

QIAGEN showcases innovation in NGS solutions for precision medicine at ASCO 2018

QIAGEN launches the DNeasy PowerSoil Pro Kit to advance microbiome characterization in soils

QIAGEN welcomes WHO’s Essential Diagnostics List which includes QuantiFERON-TB Gold

Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052/ Share Repurchase

QIAGEN reports results for first quarter 2018

QIAGEN announces FDA approval of PartoSure